Hi, interesting read and I welcome some in depth discussion on the company.
Just a quick reply. This was the base dosage of ppl-1 and it produced surprising results which were out of the ordinary and in my opinion are a pre-cursor to big things ahead. The chief investigator alluded to the surprise in the announcement. If we get similar results in canines then the sp will move massively I beleive. It just makes you wonder what impact the higher dosages will have.
This has increased the people watching the company and will most likely increase the trial sizes from now on. This is a huge plus for investors and will only add value in the not too distant future.
In regards to the cash position, we have received a large sum from our biggest customer of epichem. This was not reported in the quaterly but will be shown in the next.
- Forums
- ASX - By Stock
- PAA
- Was the recent announcement worth releasing?
Was the recent announcement worth releasing?, page-2
-
- There are more pages in this discussion • 95 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add PAA (ASX) to my watchlist
(20min delay)
|
|||||
Last
22.0¢ |
Change
0.000(0.00%) |
Mkt cap ! $86.90M |
Open | High | Low | Value | Volume |
22.5¢ | 22.5¢ | 21.0¢ | $76.79K | 352.6K |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 16022 | 21.5¢ |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
22.5¢ | 156240 | 3 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
2 | 16022 | 0.215 |
7 | 79680 | 0.210 |
4 | 193228 | 0.205 |
9 | 159603 | 0.200 |
4 | 276128 | 0.195 |
Price($) | Vol. | No. |
---|---|---|
0.225 | 156240 | 3 |
0.230 | 27851 | 4 |
0.235 | 50000 | 1 |
0.240 | 66900 | 2 |
0.245 | 56860 | 4 |
Last trade - 14.48pm 06/05/2024 (20 minute delay) ? |
|
|||||
Last
22.0¢ |
  |
Change
0.000 ( 5.72 %) |
|||
Open | High | Low | Volume | ||
23.0¢ | 23.0¢ | 21.0¢ | 271600 | ||
Last updated 15.42pm 06/05/2024 ? |
Featured News
PAA (ASX) Chart |
The Watchlist
ACW
ACTINOGEN MEDICAL LIMITED
Steven Gourlay, CEO
Steven Gourlay
CEO
Previous Video
Next Video
SPONSORED BY The Market Online